Advanced

TPS, CA 19-9, VEGF-A, and CEA as Diagnostic and Prognostic Factors in Patients with Mass Lesions in the Pancreatic Head.

Sandblom, Gabriel LU ; Granroth, Sofie and Rasmussen, Ib Christian (2008) In Uppsala Journal of Medical Sciences 113(1). p.57-64
Abstract
Introduction: Although numerous tumour markers are available for periampullary tumours, including pancreatic cancer, their specificity and sensitivity have been questioned.Materials and methods: To assess the diagnostic and prognostic values of tissue polypeptide specific antigen (TPS), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor (VEGF-A), and carcinoembryonic antigen (CEA) we took serum samples in 56 patients with mass lesions in the pancreatic head. Among these patients, further investigations revealed pancreatic cancer in 20 patients, other malignant diseases in 12 and benign conditions in 24.Results: Median CEA in all patients was 3.4 microg/L (range 0.5-585.0), median CA 19-9 was105 kU/L (range 0.6-1 300... (More)
Introduction: Although numerous tumour markers are available for periampullary tumours, including pancreatic cancer, their specificity and sensitivity have been questioned.Materials and methods: To assess the diagnostic and prognostic values of tissue polypeptide specific antigen (TPS), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor (VEGF-A), and carcinoembryonic antigen (CEA) we took serum samples in 56 patients with mass lesions in the pancreatic head. Among these patients, further investigations revealed pancreatic cancer in 20 patients, other malignant diseases in 12 and benign conditions in 24.Results: Median CEA in all patients was 3.4 microg/L (range 0.5-585.0), median CA 19-9 was105 kU/L (range 0.6-1 300 00), median TPS 123.5 U/L (range 15.0-3350) and median VEGF-A 132.5 ng/L (range 60.0-4317). Area under the curve was 0.747, standard error (standard error [SE] =0.075) for CEA, 0.716 (SE=0.078) for CA 19-9 and 0.822 (SE=0.086) for TPS in ROC plots based on the ability of the tumours to distinguish between benign and malignant conditions. None of the markers significantly predicted survival in the subgroup of patients with pancreatic cancer.Discussion: Our study shows that the markers may be used as fairly reliable diagnostic tools, but cannot be used to predict survival. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Uppsala Journal of Medical Sciences
volume
113
issue
1
pages
57 - 64
publisher
Taylor & Francis
external identifiers
  • pmid:18521799
  • scopus:46949105194
ISSN
0300-9734
language
English
LU publication?
yes
id
49e65af3-5d8d-4a2d-a6a9-eb797772b757 (old id 1035331)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed?term=TPS%2C%20CA%2019-9%2C%20VEGF-A%2C%20and%20CEA%20as%20Diagnostic%20and%20Prognostic%20Factors%20in%20Patients%20with%20Mass%20Lesions%20in%20the%20Pancreatic%20Head.
date added to LUP
2012-12-28 12:44:19
date last changed
2017-05-28 04:32:54
@article{49e65af3-5d8d-4a2d-a6a9-eb797772b757,
  abstract     = {Introduction: Although numerous tumour markers are available for periampullary tumours, including pancreatic cancer, their specificity and sensitivity have been questioned.Materials and methods: To assess the diagnostic and prognostic values of tissue polypeptide specific antigen (TPS), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor (VEGF-A), and carcinoembryonic antigen (CEA) we took serum samples in 56 patients with mass lesions in the pancreatic head. Among these patients, further investigations revealed pancreatic cancer in 20 patients, other malignant diseases in 12 and benign conditions in 24.Results: Median CEA in all patients was 3.4 microg/L (range 0.5-585.0), median CA 19-9 was105 kU/L (range 0.6-1 300 00), median TPS 123.5 U/L (range 15.0-3350) and median VEGF-A 132.5 ng/L (range 60.0-4317). Area under the curve was 0.747, standard error (standard error [SE] =0.075) for CEA, 0.716 (SE=0.078) for CA 19-9 and 0.822 (SE=0.086) for TPS in ROC plots based on the ability of the tumours to distinguish between benign and malignant conditions. None of the markers significantly predicted survival in the subgroup of patients with pancreatic cancer.Discussion: Our study shows that the markers may be used as fairly reliable diagnostic tools, but cannot be used to predict survival.},
  author       = {Sandblom, Gabriel and Granroth, Sofie and Rasmussen, Ib Christian},
  issn         = {0300-9734},
  language     = {eng},
  number       = {1},
  pages        = {57--64},
  publisher    = {Taylor & Francis},
  series       = {Uppsala Journal of Medical Sciences},
  title        = {TPS, CA 19-9, VEGF-A, and CEA as Diagnostic and Prognostic Factors in Patients with Mass Lesions in the Pancreatic Head.},
  volume       = {113},
  year         = {2008},
}